Amanda Y. F. You

Amanda Y. F. You

Auto-generated profile, based on publicly available information

Amanda Y. F. You

Department of Materials, Imperial College London, London SW7 2AZ, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Science Advances
Verified
Journal Article
Open access
PDF file
AYAmanda Y. F. You
Amanda Y. F. You
MBMads S. Bergholt
Mads S. Bergholt
JSJean-Philippe St-Pierre
Jean-Philippe St-Pierre
WKWorrapong Kit-Anan
Worrapong Kit-Anan
IPIsaac J. Pence
Isaac J. Pence
MSMolly M. Stevens
Molly M. Stevens
Raman spectroscopy of tissue biochemistry reveals the interplay between atherosclerosis and medial calcification in human aorta.

8 June 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
CHChristine-Maria Horejs
Christine-Maria Horejs
JSJean-Philippe St-Pierre
Jean-Philippe St-Pierre
JOJuha R. M. Ojala
Juha R. M. Ojala
JSJoseph A. M. Steele
Joseph A. M. Steele
PSPatricia Barros da Silva
Patricia Barros da Silva
MSMolly M. Stevens
Molly M. Stevens
Matrix metalloproteinases (MMPs) contribute to the breakdown of tissue structures such as the basement membrane, promoting tissue fibrosis. Here we developed an electrospun membrane biofunctionalized with a fragment of the laminin β1-chain to modulate the expression of MMP2 in this context. We demonstrate that interfacing of the β1-fragment with the mesothelium of the peritoneal membrane via a biomaterial abrogates the release of active MMP2 in response to transforming growth factor β1 and rescues tissue integrity ex vivo and in vivo in a mouse model of peritoneal fibrosis. Importantly, our data demonstrate that the membrane inhibits MMP2 expression. Changes in the expression of epithelial-to-mesenchymal transition (EMT)-related molecules further point towards a contribution of the modulation of EMT. Biomaterial-based presentation of regulatory basement membrane signals directly addresses limitations of current therapeutic approaches by enabling a localized and specific method to counteract MMP2 release applicable to a broad range of therapeutic targets.